Lexaria Bioscience Corp.(NASDAQ : LEXX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Consumer Non Durables » Food Major Diversified
|MDLZ||Mondelez International, Inc.||0.05%||60.46||1.1%||$392.13m|
|BYND||Beyond Meat, Inc.||0.10%||112.38||0.0%||$260.17m|
|GIS||General Mills, Inc.||-1.99%||57.58||2.2%||$239.72m|
|KHC||The Kraft Heinz Co.||-0.64%||35.98||0.9%||$203.41m|
|CPB||Campbell Soup Co.||-0.75%||42.28||2.7%||$164.36m|
|CAG||Conagra Brands, Inc.||-0.42%||33.09||1.4%||$113.23m|
|THS||TreeHouse Foods, Inc.||0.34%||38.39||10.1%||$60.45m|
|TTCF||Tattooed Chef, Inc.||-1.78%||19.35||0.0%||$40.53m|
|OTLY||Oatly Group AB||2.43%||16.44||0.0%||$32.57m|
|BGS||B&G Foods, Inc.||-0.23%||29.81||11.2%||$22.03m|
|SMPL||The Simply Good Foods Co.||1.69%||34.85||0.0%||$12.23m|
|LEXX||Lexaria Bioscience Corp.||0.47%||6.42||0.0%||$2.22m|
Lexaria Bioscience Corp. is a proprietary drug delivery technology company. Its technology DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH increases bio-absorption, reduces time of onset, and masks unwanted tastes for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.